Dr. Reddys Labs (RDY) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts RDY Hot Sheet
Join SI Premium – FREE
Dr. Reddys Labs (NYSE: RDY) reported Q2 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $997 million versus the consensus estimate of $1.02 billion.
For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- Stifel Starts Taiwan Semi (TSM) at Buy
- Stifel Starts GlobalFoundries Inc. (GFS) at Buy, Top Pick
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
